Language of Instruction
|
English
|
Level of Course Unit
|
Bachelor's Degree
|
Department / Program
|
BIOENGINEERING
|
Type of Program
|
Formal Education
|
Type of Course Unit
|
Compulsory
|
Course Delivery Method
|
Face To Face
|
Objectives of the Course
|
- Describing fundamental knowledge for bioengineering - Defining the history and program structure of bioengineering - Exploring the fields covered by bioengineering - Proposing solutions to the problems in living system with bioengineering approaches
|
Course Content
|
This course covers the history and basic concepts in bioengineering which integrates biology and medicine to engineering principles. It aims to show different branches of bioengineering generated by its interdisciplinary nature. Topics in this course include definition and history of bioengineering; biomaterials, tissue engineering, regenerative medicine, biomedical engineering, bioprocess engineering, genetics, drug delivery, nanotechnology, bioinformatics, 3D bioprinting and artificial organs.
|
Course Methods and Techniques
|
Lecture presentations
|
Prerequisites and co-requisities
|
None
|
Course Coordinator
|
Asist Prof.Dr. Mesude Bicer mesude.bicer@agu.edu.tr
|
Name of Lecturers
|
Asist Prof.Dr. MESUDE BİÇER ÇALIŞKAN
|
Assistants
|
None
|
Work Placement(s)
|
No
|
Recommended or Required Reading
Resources
|
This course covers the history and fundamental issues of bioengineering, which combines biology and medicine with basic engineering sciences. It aims to demonstrate the different branches of bioengineering due to its interdisciplinary nature. The course content includes topics such as the definition and history of bioengineering, biomaterials and tissue engineering, regenerative medicine, biomedical engineering, bioprocess engineering, genetics, drug delivery, nanotechnology, 3D printing technology, artificial organs and bioinformatics.
|
|
Lecturer's lecture notes
|
|
|
|
Term Project Presentation
|
|
Midterm and Final
|
Course Category
Engineering
|
%40
|
|
Science
|
%30
|
|
Health
|
%30
|
|
|